SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-15-008117
Filing Date
2015-06-10
Accepted
2015-06-10 17:33:22
Documents
1
Period of Report
2015-06-09

Document Format Files

Seq Description Document Type Size
1 BOCK ANNUAL BOD GRANT rrd425627.html 4  
1 BOCK ANNUAL BOD GRANT rrd425627.xml 4 4329
  Complete submission text file 0001181431-15-008117.txt   5741
Mailing Address C/O BANKAMERICA VENTURES 950 TOWER LANE STE 700 FOSTER CITY CA 94404
Business Address
BOCK LOUIS C (Reporting) CIK: 0001279735 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33415 | Film No.: 15924230

Mailing Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037
Business Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037 (858) 875-8600
Orexigen Therapeutics, Inc. (Issuer) CIK: 0001382911 (see all company filings)

IRS No.: 651178822 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations